Condition: Prostate Cancer Patients Treated by Radiotherapy · Sponsor: Ain Shams University
The aim of this study is to evaluate the efficacy and safety of hypofractionated simultaneous integrated boost volumetric arc radiation therapy (SIB - VMAT) for high-risk and very high-risk localized prostate cancer in terms of: 1. Acute and late gastrointestinal and genitourinary toxicities. 2. Evaluate the efficacy in terms of early bPFS. 3. Dosimetric evaluation in terms of target coverage and organs at risk sparing
This description comes directly from the study's public registry record.
Mohamed Alhefny, MD · +201228169673 · Alhefny@med.asu.edu.eg
Ahmed Sohaib, MD · +201060406063 · dr.ahmed.sohaib@gmail.com
Always discuss trial participation with your own doctor first.
| Faculty of Medicine, Ain Shams University | Cairo, Egypt | Recruiting |
| Faculty of Medicine - Menoufia University | Shibīn al Kawm, Egypt | Recruiting |
| Faculty of Medicine - Sohag University | Sohag, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07693075